生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | NS-398 is a novel anti-inflammatory and analgesic agent. The COX-1 activity was completely unaffected by 100μ M NS-398, whereas the COX-2 activity was concentration-dependently inhibited with IC50 of 3.8μ M[3]. NS-398 shows the anti-inflammatory and analgesic effects with the effective dose range being 0.3∼5 mg/kg in rats[4].In vitro experiments, NS-398 inhibited the proliferation and maturation of differentiated myogenic precursor cells, which suggested a detrimental effect on skeletal muscle healing. In the NS-398-treated mice, muscle regeneration delayed at early time points after injury[5].NS-398 decreased the regeneration of injured muscle by delaying the maturation of regenerating myofibers, and promoted fibrosis by up-regulating TGF-β1 expression. NS-398 administration also reduced the inflammatory response and up-regulated myostatin expression[5]. NS-398 (10 mM) can induce apoptosis in LNCaP cells[6]. When treated with NS-398, the C4-2b cells were observed to continue to proliferate and continued to retain malignant phenotype characteristics. NS-398 treatment resulted in C4-2b cell differentiation into an unusual neuroendocrine-like cell which produced both epithelial and neuronal proteins. Moreover, this C4-2b cellular response to NS-398 was mediated by NF-kappa beta transcription factor activation[6]. Cox-2 is involved in the pathogenesis of Noise-induced hearing loss (NIHL), and pre-treatment with the Cox-2 inhibitor NS398 could inhibit Cox-2 expression during noise overstimulation attenuating noise-induced hearing loss and hair cell damage[7]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
HaCaT cells | Function assay | 24 h | Inhibition of PGE2 production in human HaCaT cells after 24 hrs by RIA, IC50=0.01 μM | 15387642 | |
HUVEC | Function assay | 18 h | Antiangiogenic activity against VEGFA-stimulated capillary differentiation in HUVEC after 18 hrs by matrigel assay | 23110475 | |
HUVEC | Function assay | 48 h | Antiangiogenic activity against VEGFA-stimulated cell proliferation in HUVEC after 48 hrs by BrdU incorporation assay | 23110475 |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00172627 | - | Unknown | - | Taiwan ... 展开 >> Shih-Pei Huang Recruiting Taipei, Taiwan Contact: Shih-Pei Huang, MD 886-2-23123456 ext 3353 dtmeda5@ha.mc.ntu.edu.tw 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.18mL 0.64mL 0.32mL |
15.91mL 3.18mL 1.59mL |
31.81mL 6.36mL 3.18mL |
参考文献 |
---|